pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    Oncotice
    Tice BCG
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$MRK Merck & Co., Inc.
  • Marketed
    Onyda XR
    Onyda XR (clonidine hydrochloride)
    Attention Deficit Hyperactivity Disorder (ADHD) Tris Pharma Inc
  • Phase 2
    OpRegen
    OpRegen
    Geographic Atrophy F. Hoffmann-La Roche Ltd
  • Phase 2
← prev
page 138 of 271
next →
Pain89
Neurology1
Optiquel
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
  • Marketed
    Opzelura
    Opzelura (ruxolitinib phosphate)
    Hidradenitis Suppurativa$INCY INCYTE CORP
  • Marketed
    Orabloc
    Orabloc ((articaine hydrochloride + epinephrine bitartrate))
    Local Anesthetic Effect Pierrel SpA
  • Phase 2
    Oral Psilocybin
    psilocybin
    Substance (Drug) Abuse Revive Therapeutics Ltd
  • Marketed
    Oraqix
    Oraqix ((lidocaine + prilocaine))
    Local Anesthetic Effect DENTSPLY Pharmaceutical
  • Phase 2
    Organ Dysfunction/Mortality
    Unspecified BioAegis Therapeutics Inc
  • Phase 2
    OriCAR-017
    Refractory Multiple Myeloma Oricell Therapeutics (Shanghai) Co Ltd
  • Preclinical
    Oximo
    Genital Herpes Oxymo Technologies Inc
  • Marketed
    Oxsoralen-Ultra
    Methoxsalen Oceanside (methoxsalen)
    Psoriasis Bausch Health US LLC
  • Preclinical
    Oxy-133
    Osteoporosis Max Biopharma Inc
  • Preclinical
    Oxy-210
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Max Biopharma Inc
  • Marketed
    Oxybutynin Chloride Teva
    Oxybutynin Chloride
    Dysuria Teva Pharmaceuticals USA Inc
  • pre_registration
    Ozempic
    Ozempic (semaglutide)
    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Di… Novo Nordisk AS
  • Phase 1
    P-01
    Pancreatic Cancer Hangzhou Neoantigen Therapeutics Co Ltd
  • Preclinical
    P-1155
    Chronic Obstructive Pulmonary Disease (COPD) Parion Sciences Inc
  • Phase 2
    P-12
    Burns NeoMatrix Therapeutics Inc
  • Phase 2
    P-4M01
    Periodontal Disease P4 Microbiome Inc
  • Preclinical
    P-8
    Alzheimer's Disease Cenna Biosciences Inc
  • Preclinical
    P-BCMACD19-ALLO1
    Autoimmune Disorders Poseida Therapeutics Inc
  • Preclinical
    P-MAPA
    Schistosomiasis Farmabrasilis
  • Preclinical
    P5P Analogues
    Unspecified$MCUJF MEDICURE INC
  • Phase 1
    PA-001
    Coronavirus Disease 2019 (COVID-19) PeptiAID Inc
  • PADCEV
    PADCEV (ENFORTUMAB VEDOTIN-EJFV)
    no indication Astellas Pharma Inc
  • Phase 2
    PALI-2108
    Ulcerative Colitis$PALI PALISADE BIO, INC.
  • PALIPERIDONE
    PALIPERIDONE
    no indication Apotex Corp
  • PALSONIFY
    PALSONIFY (PALTUSOTINE HYDROCHLORIDE)
    1 INDICATIONS AND USAGE PALSONIFY is indicated for the tr…$CRNX Crinetics Pharmaceuticals, Inc.
  • PANRETIN
    PANRETIN (ALITRETINOIN)
    no indication Advanz Pharma Corp Ltd